Michael Heltzen
President & CEOMr. Michael Heltzen has been Chief Executive Officer at eXoZymes, Inc. (formerly known as Invizyne Technologies, Inc.) since February 01, 2024 and serves as its President since February 17, 2025. Mr. Heltzen held the position of Executive Vice President for Strategy at Paragraf Ltd. from May 2023 to October 2023. He served as the Chief Executive Officer at of Cardea Bio Inc. and was its Board Member. He has an extensive background in tech business development in Bioinformatics, Next-Gen Sequencing, Genomics and Intercellular communication. He has held leadership positions in CLC bio, BGI, EXO Incubator, Nanosens and BlueSEQ. previously served as the Chief Strategy Officer of eXoZymes, Inc. (formerly known as Invizyne Technologies, Inc.) from October 2023 to January 2024. Mr. Heltzen has also served as the Chairman of the Board for EXO Incubator Inc. since 2015 and Chairman of the Board for Blue SEQ Innovations Inc. since 2010. Mr. Heltzen also served as the Chief Executive Officer and Chairman of Nanosens Innovations Inc.
Positions
- Company NameeXoZymes, Inc.Stock CodeEXOZPositionPresident & CEOColleagues
- CAChristopher A. MarlettChairman
- TKTyler KormanCo-Founder & Chief Scientific Officer
- POPaul OpgenorthCo-Founder & Vice President of Development
- JUJames U. BowieFounder & Independent Director
- FNFouad NawazVP of Finance and Principal Financial & Accounting Officer
- LELon Edward BellIndependent Director
- JJJames J. LalondeIndependent Director
- YTYi TangMember of Scientific Advisory Board
